Puma Biotechnology Inc.

NASDAQ: PBYI · Real-Time Price · USD
5.22
0.11 (2.15%)
At close: Aug 21, 2025, 11:59 AM

Puma Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
48.45M 38.07M 30.28M 23.24M 8.72M 15.38M 21.59M 3.72M -2.44M 4.81M 2K 9.83M -34.48M -49.06M -29.13M -48.34M -35.13M -26.53M
Depreciation & Amortization
11.28M 11.42M 11.52M 11.57M 11.57M 11.54M 11.52M 10.84M 10.19M 9.77M 9.16M 9.22M 9.44M 9.91M 10.6M 11.28M 11.77M 11.07M
Stock-Based Compensation
7.46M 7.89M 8.24M 8.93M 9.42M 9.79M 10.25M 10.44M 10.73M 11.52M 11.83M 13.45M 14.9M 29.92M 32.63M 37.85M 41.14M 33.53M
Other Working Capital
-10.35M -13.85M -16.86M 10.24M -4.46M -5.46M -7.38M 2.65M 5.72M 4.96M -9.06M -29.07M -5.12M -17.17M 9.94M 4.72M 5.8M 15.58M
Other Non-Cash Items
-595K -416K -519K 27.26M 25.51M 24.03M 20.55M 165K -3.01M 1.08M 4.46M -2.54M 10.58M 7.15M 25.24M 26.24M 18.85M 14.36M
Deferred Income Tax
-7.08M -7.08M -7.08M -27.01M -24.59M -22.41M -19.04M 7.97M 10.53M 8.35M 4.97M 4.97M n/a n/a n/a 27K 27K 27K
Change in Working Capital
-15.18M -18.61M -3.54M -10.22M 2.72M -2.7M -17.85M -8.9M 4.89M -19.38M -43.81M -61.45M -33.71M -19.83M -602K 11.52M -6.1M 8.91M
Operating Cash Flow
44.34M 31.28M 38.92M 33.77M 33.34M 35.61M 27.01M 24.24M 30.88M 13.71M -15.83M -28.95M -35.71M -21.91M 20.65M 20.48M 11.7M 28M
Capital Expenditures
-117K -117K -56K -85K -92K -140K -12.64M -19.59M -19.57M -19.5M -7M n/a n/a n/a n/a -10.02M -10.03M -10.05M
Cash Acquisitions
n/a n/a n/a 8.13M -3.08M -3.01M -3.01M -4.14M 7.07M 7M 7M n/a n/a n/a n/a -103K -103K -103K
Purchase of Investments
-65.76M -63.76M -76.23M -72.26M -58.16M -43.84M -23.81M -17.35M -15.38M -9.79M -4.84M n/a -18.96M -27.38M -38.07M -43.47M -32.57M -40.52M
Sales Maturities Of Investments
54.1M 64.05M 55.85M 46.05M 42.88M 23.22M 17.33M 14.11M 8.94M 9.96M 18.94M 23.6M 30.09M 30.78M 27.19M 38.81M 29.81M 44.29M
Other Investing Acitivies
n/a n/a n/a -8.13M 3.08M 3.01M -14.44M -13.31M -16.52M -14.46M 11.98M 23.6M 11.13M 3.4M -10.88M -4.66M -2.75M -7.03M
Investing Cash Flow
-11.78M 173K -20.44M -26.29M -15.37M -20.75M -19.13M -22.83M -26.01M -19.33M 7.1M 23.6M 11.13M 3.4M -10.88M -14.78M -12.89M -16.38M
Debt Repayment
-44.44M -44.44M -33.33M -22.22M -11.11M n/a n/a n/a n/a n/a n/a n/a -1.5M -1.5M -1.5M -1.5M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-758K -888K -666K -445K -222K n/a n/a -69K -122K -122K -277K -210K -30.59M -30.59M -30.43M -30.41M 66K 68K
Financial Cash Flow
-45.05M -45.18M -33.85M -22.52M -11.33M n/a n/a 2.43M 2.38M 2.38M 12.22M 9.79M -22.09M -22.09M -31.93M -31.87M 98K 100K
Net Cash Flow
-12.49M -13.72M -15.37M -15.04M 6.64M 14.86M 7.88M 3.84M 7.25M -3.24M 3.5M 4.44M -46.66M -40.59M -22.16M -26.14M -1.05M 11.77M
Free Cash Flow
44.22M 31.17M 38.86M 33.68M 33.25M 35.47M 14.37M 4.64M 11.31M -5.79M -22.83M -28.95M -35.71M -21.91M 20.65M 10.45M 1.67M 17.95M